BALJINDER KAUR: Open Payments
NPI 1336916188 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Phadia US Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Seqirus USA Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: ImmunoCAP, ZORYVE, NEFFY, ROTATEQ, Flucelvax, BEXSERO.
Industry payments across CA — which companies pay providers there.
